Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP)

Journal of Biological Chemistry

Volumn 288, Issue 1, 2013, Pages 306-318

  Mou, Lingyun ^a   Kang, Yawei ^a   Zhou, Ying ^a   Zeng, Qian ^a   Song, Hongjing ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM MOBILIZATION; CELL MIGRATION; GLIOBLASTOMAS; GLIOMA CELLS; MATRIX METALLOPROTEINASE-2; MATRIX METALLOPROTEINASES; MEMBRANE TYPES; METALLOPROTEINASES; MIGRATION EFFECTS; PHOSPHOLIPASE C; REPORTER GENE ASSAYS; SPECIFIC INHIBITORS; TUMOR CELL MIGRATION; UP-REGULATION;

CELL PROLIFERATION; PHOSPHORYLATION;

TUMORS;

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; GELATINASE A; HEMOKININ 1; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; NEUROKININ 1 RECEPTOR; PHOSPHOLIPASE C; PROTEIN C JUN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME REPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC AMP; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; NF-KAPPA B; PEPTIDES; RECEPTORS, NEUROKININ-1; TACHYKININS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 84872071680     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.389783     Document Type: Article

References (52)

1. Davis, F. G., Freels, S., Grutsch, J., Barlas, S., and Brem, S. (1998) Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type. An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J. Neurosurg. 88, 1-10
2. Nakada, M., Nakada, S., Demuth, T., Tran, N. L., Hoelzinger, D. B., and Berens, M. E. (2007) Molecular targets of glioma invasion. Cell. Mol. Life Sci. 64, 458-478
3. Stylli, S. S., Kaye, A. H., and Lock, P. (2008) Invadopodia. At the cutting edge of tumour invasion. J. Clin. Neurosci. 15, 725-737
4. Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R. C., Ludwin, S. K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J. G., Eisenhauer, E., Mirimanoff, R. O., European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, and National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (Pubitemid 40349501)
5. Koul, D., Shen, R., Bergh, S., Sheng, X., Shishodia, S., and Lafortune, T. A. (2006) Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma. Mol. Cancer Ther. 5, 637-644
6. Palma, C. (2006) Tachykinins and their receptors in human malignancies. Curr. Drug Targets 7, 1043-1052
7. Muñoz, M., Rosso, M., and Coveñas, R. (2011) The NK-1 receptor. A new target in cancer therapy. Curr. Drug Targets 12, 909-921
8. Reubi, J. C., Mäcke, H. R., and Krenning, E. P. (2005) Candidates for peptide receptor radiotherapy. Today and in the future. J. Nucl. Med. 46, 67-75
9. Page, N. M. (2005) New challenges in the study of the mammalian tachykinins. Peptides 26, 1356-1368
10. Hennig, I. M., Laissue, J. A., Horisberger, U., and Reubi, J. C. (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int. J. Cancer 61, 786-792
11. Łazarczyk, M., Matyja, E., and Lipkowski, A. (2007) Substance P and its receptors - a potential target for novel medicines in malignant brain tumour therapies (mini-review). Folia Neuropathol. 45, 99-107 (Pubitemid 47520857)
12. Berger, A., and Paige, C. J. (2005) Hemokinin-1 has substance P-like function in U-251 MG astrocytoma cells. A pharmacological and functional study. J. Neuroimmunol. 164, 48-56 (Pubitemid 40826762)
13. Palma, C., Nardelli, F., Manzini, S., and Maggi, C. A. (1999) Substance P activates responses correlated with tumor growth in human glioma cell lines bearing tachykinin NK1 receptors. Br. J. Cancer 79, 236-243 (Pubitemid 29002291)
14. Ogo, H., Kuroyanagi, N., Inoue, A., Nishio, H., Hirai, Y., Akiyama, M., DiMaggio, D. A., Krause, J. E., and Nakata, Y. (1996) Human astrocytoma cells (U-87 MG) exhibit a specific substance P-binding site with the characteristics of an NK-1 receptor. J. Neurochem. 67, 1813-1820 (Pubitemid 26349653)
15. Luo, W., Sharif, T. R., and Sharif, M. (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res. 56, 4983-4991 (Pubitemid 26374439)
16. Akazawa, T., Kwatra, S. G., Goldsmith, L. E., Richardson, M. D., Cox, E. A., Sampson, J. H., and Kwatra, M. M. (2009) A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas. J. Neurochem. 109, 1079-1086
17. Mitsuhashi, M., Ohashi, Y., Shichijo, S., Christian, C., Sudduth-Klinger, J., Harrowe, G., and Payan, D. G. (1992) Multiple intracellular signaling pathways of the neuropeptide substance P receptor. J. Neurosci. Res. 32, 437-443
18. Lieb, K., Fiebich, B. L., Berger, M., Bauer, J., and Schulze-Osthoff, K. (1997) The neuropeptide substance P activates transcription factor NF-κB and κB-dependent gene expression in human astrocytoma cells. J. Immunol. 159, 4952-4958 (Pubitemid 127471032)
19. Christian, C., Gilbert, M., and Payan, D. G. (1994) Stimulation of transcriptional regulatory activity by substance P. Neuroimmunomodulation 1, 159-164
20. Eistetter, H. R., Mills, A., Brewster, R., Alouani, S., Rambosson, C., and Kawashima, E. (1992) Functional characterization of neurokinin-1 receptors on human U373MG astrocytoma cells. Glia 6, 89-95
21. Koon, H. W., Zhao, D., Zhan, Y., Moyer, M. P., and Pothoulakis, C. (2007) Substance P mediates antiapoptotic responses in human colonocytes by Akt activation. Proc. Natl. Acad. Sci. U.S.A. 104, 2013-2018 (Pubitemid 46239895)
22. Guha, A., and Mukherjee, J. (2004) Advances in the biology of astrocytomas. Curr. Opin. Neurol. 17, 655-662 (Pubitemid 39612996)
23. Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., and Brennan, C. (2007) Malignant astrocytic glioma. Genetics, biology, and paths to treatment. Gene Dev. 21, 2683-2710 (Pubitemid 350070717)
24. Ziche, M., Morbidelli, L., Pacini, M., Geppetti, P., Alessandri, G., and Maggi, C. A. (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc. Res. 40, 264-278 (Pubitemid 20327679)
25. Guha, S., Eibl, G., Kisfalvi, K., Fan, R. S., Burdick, M., Reber, H., Hines, O. J., Strieter, R., and Rozengurt, E. (2005) Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP. A dual inhibitor of growth and angiogenesis in pancreatic cancer. Cancer Res. 65, 2738-2745 (Pubitemid 40490075)
26. Song, H., Yin, W., Zeng, Q., Jia, H., Lin, L., Liu, X., Mou, L., and Wang, R. (2012) Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor. Int. J. Biochem. Cell B. 44, 1410-1421
27. Feistritzer, C., Clausen, J., Sturn, D. H., Djanani, A., Gunsilius, E., Wiedermann, C. J., and Kähler, C. M. (2003) Natural killer cell functions mediated by the neuropeptide substance P. Regul. Pept. 116, 119-126 (Pubitemid 37352922)
28. Schratzberger, P., Reinisch, N., Prodinger, W. M., Kähler, C. M., Sitte, B. A., Bellmann, R., Fischer-Colbrie, R., Winkler, H., and Wiedermann, C. J. (1997) Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J. Immunol. 158, 3895-3901 (Pubitemid 127488749)
29. Ruff, M. R., Wahl, S. M., and Pert, C. B. (1985) Substance P receptor-mediated chemotaxis of human monocytes. Peptides 6, 107-111 (Pubitemid 16211115)
30. Meshki, J., Douglas, S. D., Lai, J.-P., Schwartz, L., Kilpatrick, L. E., and Tuluc, F. (2009) Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism. J. Biol. Chem. 284, 9280-9289
31. Meshki, J., Douglas, S. D., Hu, M., Leeman, S. E., and Tuluc, F. P. (2011) Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner. PloS ONE 6, e25332
32. Dzwonek, J., Rylski, M., and Kaczmarek, L. (2004) Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567, 129-135 (Pubitemid 38686435)
33. Yong, V. W., Power, C., Forsyth, P., and Edwards, D. R. (2001) Metalloproteinases in biology and pathology of nervous system. Neuroscience 2, 502-511 (Pubitemid 33676585)
34. Rao, J. S. (2003) Molecular mechanisms of glioma invasiveness. The role of proteases. Nat. Rev. Cancer 3, 489-501
35. Vanmeter, T. E., Rooprai, H. K., Kibble, M. M., Fillmore, H. L., Broaddus, W. C., and Pilkington, G. J. (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J. Neuro-oncol. 53, 213-235 (Pubitemid 33034693)
36. Clark, I. M., Swingler, T. E., Sampieri, C. L., and Edwards, D. R. (2008) The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40, 1362-1378
37. Nishida, Y., Miyamori, H., Thompson, E. W., Takino, T., Endo, Y., and Sato, H. (2008) Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Cancer Res. 68, 9096-9104
38. Mou, L., Xing, Y., Kong, Z., Zhou, Y., Chen, Z., and Wang, R. (2011) The N-terminal domain of human hemokinin-1 influences functional selectivity property for tachykinin receptor neurokinin-1. Biochem. Pharmacol. 81, 661-668
39. Nakajima, Y., Tsuchida, K., Negishi, M., Ito, S., and Nakanishi, S. (1992) Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J. Biol. Chem. 267, 2437-2442
40. Sagan, S., Chassaing, G., Pradier, L., and Lavielle, S. (1996) Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. J. Pharmacol. Exp. Ther. 276, 1039-1048 (Pubitemid 3041415)
41. Janelsins, B. M., Mathers, A. R., Tkacheva, O. A., Erdos, G., Shufesky, W. J., Morelli, A. E., and Larregina, A. T. (2009) Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood 113, 3017-3026
42. Wang, W., Li, Q., Zhang, J., Wu, H., Yin, Y., Ge, Q., and Zhang, Y. (2010) Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production. J. Immunol. 184, 3590-3597
43. Kwiatkowska, A., Kijewska, M., Lipko, M., Hibner, U., and Kaminska, B. (2011) Down-regulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and down-regulates MMPs expression. Biochim. Biophys. Acta 1813, 665-667
44. Yan, C., and Boyd, D. D. (2007) Regulation of matrix metalloproteinase gene expression. J. Cell Physiol. 211, 19-26 (Pubitemid 46363892)
45. Lohi, J., Lehti, K., Valtanen, H., Parks, W. C., and Keski-Oja, J. (2000) Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 242, 75-86 (Pubitemid 30065091)
46. Reddy, B. Y., Trzaska, K. A., Murthy, R. G., Navarro, P., and Rameshwar, P. (2008) Neurokinin receptors as potential targets in breast cancer treatment. Curr. Drug Discov. Technol. 5, 15-19 (Pubitemid 351364569)
47. Kurtz, M. M., Wang, R., Clements, M. K., Cascieri, M. A., Austin, C. P., Cunningham, B. R., Chicchi, G. G., and Liu, Q. (2002) Identification, localization, and receptor characterization of novel mammalian substance P-like peptides. Gene 296, 205-212 (Pubitemid 35287339)
48. Page, N. M., Bell, N. J., Gardiner, S. M., Manyonda, I. T., Brayley, K. J., Strange, P. G., and Lowry, P. J. (2003) Characterization of the endokinins. Human tachykinins with cardiovascular activity. Proc. Natl. Acad. Sci. U.S.A. 100, 6245-6250 (Pubitemid 36576961)
49. Molina, J. R., Hayashi, Y., Stephens, C., and Georgescu, M. M. (2010) Invasive glioblastoma cells acquire stemness and increased Akt activation 12. Neoplasia 12, 453-463
50. Lu, D. Y., Leung, Y. M., Cheung, C. W., Chen, Y. R., and Wong, K. L. (2010) Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells. Biochem. Pharmacol. 80, 1201-1209
51. Sakai, A., Takasu, K., Sawada, M., and Suzuki, H. (2012) Hemokinin-1 gene expression is up-regulated in microglia activated by lipopolysaccharide through NF-κB and p38 MAPK signaling pathways. PLoS ONE 7, e32268
52. Matsumura, T., Sakai, A., Nagano, M., Sawada, M., Suzuki, H., Umino, M., and Suzuki, H. (2008) Increase in hemokinin-1 mRNA in the spinal cord during the early phase of a neuropathic pain state. Br. J. Pharmacol. 155, 767-774